Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Feb 8, 2019.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6146-25
Dosage Form
Injection
Presentation
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)
Initial Posting
Feb 8, 2019

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.